| Intrinsic Valuation of: FITB | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 3 | Market Cap | $43B | |||||
| 2021 | - | - (-) | P/E Ratio | 16 | Total Asset | $214B | |||||
| 2022 | $6B | - (-) | Net Income | $3B | Total Debt | $14B | |||||
| 2023 | $4B | -30.5% (-33.2%) | EBITDA | - | Total Liab | $193B | |||||
| 2024 | $2B | -39.6% (-38.5%) | Opr Margin | - | Debt/Equity | 0.63 | |||||
| 2025 | $4B | 57.9% (48.1%) | PreTax Margin | - | BV/Share | 15 | |||||
| 5Y Average FCF | $4B | 2.9% (-7.9%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 8.91% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (2.9%) | ||||||||||
| 2026 | $4B | MBG Intrinsic Value | $27 | ||||||||
| 2027 | $4B | ||||||||||
| 2028 | $4B | ||||||||||
| 2029 | $4B | ||||||||||
| 2030 | $4B | ||||||||||
| 2031 | $5B | ||||||||||
| Terminal Value | $72B | Net Worth/Share | $24 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $62B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $3B | $58 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $14B | WACC | 6.9% | 74 | 80 | 89 | 99 | 112 | |||
| Equity Value | $52B | 7.9% | 60 | 65 | 70 | 77 | 84 | ||||
| Shares Outstanding | 906,311,548 | 8.9% | 51 | 54 | 58 | 62 | 67 | ||||
| 9.9% | 43 | 46 | 48 | 51 | 55 | ||||||
| DCF Intrinsic Value | $58 | 10.9% | 38 | 39 | 41 | 43 | 46 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||